Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia

CONCLUSION: Androgen receptor antagonist MDV3100 alleviates BPH and inflammatory response through miR-21-3p downregulation and NF-κB signaling pathway blockade.PMID:34610715 | PMC:PMC8497737 | DOI:10.5213/inj.2142004.002

Source: International Neurourology Journal - October 6, 2021 Category: Urology & Nephrology Authors: Minggen Yang Zhenqiang Xu Zhiming Zhuang Source Type: research